United States
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 7.78 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
2 |
USD 6.49 B
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
3 |
USD 3.21 B
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
4 |
USD 3.07 B
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
5 |
USD 1.97 B
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
6 |
USD 1.70 B
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
7 |
USD 1.68 B
|
Sept. 30, 2024 | USD 179.15 | 1.50% |
|
United States |
|
8 |
USD 1.35 B
|
Sept. 30, 2024 | USD 228.83 | -0.62% |
|
United States |
|
9 |
USD 1.17 B
|
Sept. 30, 2024 | USD 70.19 | 2.45% |
|
United States |
|
10 |
USD 1.16 B
|
Sept. 30, 2024 | USD 104.71 | -0.74% |
|
United States |
|
11 |
USD 1.15 B
|
Sept. 28, 2024 | USD 70.20 | -0.13% |
|
United States |
|
12 |
USD 888.63 M
|
Sept. 30, 2024 | USD 1.27 K | 0.33% |
|
United States |
|
13 |
USD 535.00 M
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
14 |
USD 502.20 M
|
Sept. 30, 2024 | USD 71.04 | -0.07% |
|
United States |
|
15 |
USD 451.98 M
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
16 |
USD 450.04 M
|
Sept. 29, 2024 | USD 179.17 | 0.35% |
|
United States |
|
17 |
USD 390.00 M
|
Sept. 30, 2024 | USD 111.11 | 1.26% |
|
United States |
|
18 |
USD 373.02 M
|
Sept. 30, 2024 | USD 210.46 | -1.51% |
|
United States |
|
19 |
USD 359.40 M
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
20 |
USD 293.77 M
|
Sept. 30, 2024 | USD 88.18 | 1.15% |
|
United States |
|
21 |
USD 229.32 M
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
22 |
USD 224.60 M
|
Sept. 30, 2024 | USD 267.04 | -0.35% |
|
United States |
|
23 |
USD 222.31 M
|
Sept. 30, 2024 | USD 50.77 | 2.13% |
|
United States |
|
24 |
USD 172.71 M
|
Sept. 30, 2024 | USD 99.89 | 4.44% |
|
United States |
|
25 |
USD 167.85 M
|
Sept. 30, 2024 | USD 161.08 | 1.85% |
|
United States |
|
26 |
USD 166.13 M
|
Sept. 30, 2024 | USD 67.79 | -2.46% |
|
United States |
|
27 |
USD 156.70 M
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
28 |
USD 149.60 M
|
Sept. 28, 2024 | USD 166.09 | 0.31% |
|
United States |
|
29 |
USD 134.18 M
|
Sept. 30, 2024 | USD 252.89 | 2.41% |
|
United States |
|
30 |
USD 126.96 M
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
31 |
USD 104.13 M
|
Sept. 27, 2024 | USD 148.22 | 1.40% |
|
United States |
|
32 |
USD 73.40 M
|
Sept. 27, 2024 | USD 138.83 | 2.72% |
|
United States |
|
33 |
USD 64.00 M
|
Sept. 30, 2024 | USD 3.67 | -0.81% |
|
United States |
|
34 |
USD 55.00 M
|
Sept. 30, 2024 | USD 16.29 | 2.65% |
|
United States |
|
35 |
USD 39.72 M
|
Sept. 30, 2024 | USD 17.46 | 1.51% |
|
United States |
|
36 |
USD 38.04 M
|
Sept. 30, 2024 | USD 21.93 | -1.62% |
|
United States |
|
37 |
USD 37.88 M
|
Sept. 28, 2024 | USD 79.96 | 0.69% |
|
United States |
|
38 |
USD 36.60 M
|
Sept. 30, 2024 | USD 15.83 | 0.19% |
|
United States |
|
39 |
USD 35.78 M
|
Sept. 30, 2024 | USD 131.05 | -0.04% |
|
United States |
|
40 |
USD 33.49 M
|
Sept. 30, 2024 | USD 95.85 | 1.78% |
|
United States |
|
41 |
USD 27.16 M
|
Sept. 28, 2024 | USD 8.87 | -3.17% |
|
United States |
|
42 |
USD 25.07 M
|
Sept. 30, 2024 | USD 3.05 | -0.33% |
|
United States |
|
43 |
USD 25.04 M
|
Sept. 30, 2024 | USD 15.44 | -1.72% |
|
United States |
|
44 |
USD 19.90 M
|
Sept. 30, 2024 | USD 20.10 | 0.95% |
|
United States |
|
45 |
USD 18.98 M
|
Sept. 28, 2024 | USD 22.64 | 0.85% |
|
United States |
|
46 |
USD 18.20 M
|
Sept. 27, 2024 | USD 13.52 | 1.05% |
|
United States |
|
47 |
USD 17.16 M
|
Sept. 30, 2024 | USD 57.52 | 1.79% |
|
United States |
|
48 |
USD 17.14 M
|
Sept. 30, 2024 | USD 61.49 | 0.77% |
|
United States |
|
49 |
USD 16.93 M
|
Sept. 28, 2024 | USD 105.78 | 2.21% |
|
United States |
|
50 |
USD 15.60 M
|
Sept. 30, 2024 | USD 7.66 | -1.42% |
|
United States |
The Medical Instruments company in United States with the highest Free Cash Flow is Thermo Fisher Scientific Inc. (NYSE: TMO) at USD 7.78 B.
The Medical Instruments company in United States with the lowest Free Cash Flow is Heart Test Laboratories, Inc. (NasdaqCM: HSCS) at USD -4.21 B.
The top 10 Medical Instruments companies in United States by Free Cash Flow are Thermo Fisher Scientific Inc., Abbott Laboratories, Stryker Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, GE HealthCare Technologies Inc., AMETEK, Inc., ResMed Inc., Solventum Corporation and Zimmer Biomet Holdings, Inc..
The bottom 10 Medical Instruments companies in United States by Free Cash Flow are Heart Test Laboratories, Inc., Standard BioTools Inc., Outset Medical, Inc., TransMedics Group, Inc., QuidelOrtho Corporation, iRhythm Technologies, Inc., Nevro Corp., Enovis Corporation, Butterfly Network, Inc. and OrthoPediatrics Corp..